ATYR

Atyr Pharma Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 3/10
  • Momentum↓ 2/10
Atyr Pharma sales and earnings growth
ATYR Growth
Neutral
  • Revenue Y/Y↓ -19.15%
  • EPS Y/Y↑ 12.77%
  • FCF Y/Y↑ 6.14%
Atyr Pharma gross and profit margin trends
ATYR Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -39537.90%
  • ROIC↓ -88.10%
Atyr Pharma net debt vs free cash flow
ATYR Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.1
  • Interest coverage↓ NA

Atyr Pharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗